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Abstract 
Objective: The objective of this EBM review is to determine whether or not a daily vitamin 
supplement is effective treatment for recurrent aphthous ulcers.  !
Study Design:  A review of 3 randomized control trials.  All three trials are in English be-
tween 2009-2014. !
Data Sources: 3 randomized double blind placebo-controlled parallel-arm single center tri-
als 
were found using PubMed.   !
Outcomes Measured: Each of the RCTs measured the efficacy of treatment for RAU in pa-
tients with aphthous ulcer outbreaks for at least a year or at least one to three outbreaks a 
month.  This was performed by subjects of the study reporting on efficacy of each a daily 
multivitamin, Omega-3 supplement or Vitamin B12 supplement following the recommend-
ed daily intake scale.  
  
Results: All three RTCs were used in this review and it was determined that a daily vitamin 
supplement did not lead to any significant life-threatening conditions.   !
Conclusions: Based on the three trials, only the multivitamin supplement proved to be inef-
fective in the treatment of recurrent aphthous ulcers in adults.  Both the Omega-3 and Vit-
amin B12 proved to be both cost-effective and improved the quality of life for patients with 
RAU.    !
Key Words: Recurrent Aphthous Ulcers, RAU, Canker Sores, Vitamin, Multivitamin, 
Omega-3, Vitamin B12 
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INTRODUCTION 
Recurrent Aphthous Ulcers is a condition in which patients develop painful ulcerations in 
the mouth along the hard and soft palate, gum line, inner sides of the lips, sublingually and 
directly on the tongue.  This may interfere with a person’s ability to eat or maintain daily oral 
hygiene and speech secondary to pain.1,2  Aphthous ulcers are categorized as minor, major and 
herpetiform lesions with minor being the most commonly seen.2,3  RAU can be a debilitating 
disorder caused by painful ulcerations which heal and leave scars after several weeks and 
contribute to decreased quality of life and increased morbidity.2  This paper reviews three 
randomized control trials detailing the efficacy of taking a daily vitamin supplement orally for 
the treatment of recurrent aphthous ulcers. 
Recurrent Aphthous Ulcer disorder is the most common oral disorder in North America 
and affects 2.5 billion people world-wide.1,2   Aphthous ulcers may indicate underlying disease 
and may act as an indicator for disorders like Celiac disease, however they may be a featured 
along with Behçet’s and Inflammatory bowel disease.4   Because of its relevance to this country 
and effects on quality of life it is relevant to the PA profession.  The annual medical cost and 
healthcare visits regarding this disorder is unknown.   
The exact cause of RAU is unknown however they are believed to be induced by 
physical, mental or emotional stress, autoimmune disorders and allergies and may even be 
related to genetics. 2 Certain foods including: Spicy, acidic or salty, citric fruits, chocolate and 
alcohols may trigger and prolong the duration of the ulcers.5 
Current treatment regimens used to treat RAU include topical mouthwashes to systemic 
oral medications.1 Determining associated features with RAU disorder may be beneficial in 
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selecting an appropriate treatment method.  Topical agents used include: gel, creams, ointments 
or mouthwashes of Chlorhexidine, Hyaluronic acid and Amelanox.3  If a patient does not respond 
to topical treatments they may require systemic treatment.3  These treatments include: 
Colchicine, Levamisole and Corticosteroids.3   Local anesthetics such as tetracaine and 
polidocanol or benzocaine and cetylpyridinium can be used for symptom relief but are not 
proven to treat the ulcer.5  More significant measures taken to control ulcer eruption includes 
laser therapy and cryotherapy but should be performed by an oral specialist to avoid destroying 
healthy tissue surrounding the ulcer.1,5  
There is no current solitary treatment or cure for RAU and without an exact cause 
identified it is difficult to determine the best route for success.  However, there are successful 
treatment modalities, such as the ones listed above, for most patients which are consistent with 
the disease as it presents differently in each patient.  This topic is nominated to address a more 
cost-effective and safe treatment option in order to decrease morbidity and increase the quality of 
life for patients suffering from RAU. The objective of this evidence based medicine review is to 
determine whether or not a daily vitamin supplement is effective treatment for recurrent aphthous 
ulcers.  
METHODS 
Three randomized double blind placebo-controlled parallel-arm single center trials were 
used in this study.  The population included adult patients suffering from recurrent aphthous 
ulcers ranging from age thirteen and older.  The intervention included a daily vitamin 
supplement: Multivitamins, Omega-3 and Vitamin B12.  Each study was divided into two groups 
and compared to the placebo supplement for efficacy of treatment.  All three of the studies also 
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described utilizing specific parameters for treatment efficacy including: decrease in pain, number 
of new outbreaks and duration of current ulcer outbreak.2,3,4  In the beginning of Lalla’s, Khouli’s 
and Volkov’s studies patients were measured at baseline and again at intervals determined by the 
study.  In the Lalla study patients were given one generic multivitamin by mouth containing U.S. 
RDI of A, B1,B2, B3, B5, B6, B9, B12, C, D, and E2.  The Khouli study had patients taking 1 g 
of Omega-3 orally TID and Volkov’s study had patients taking 1000mcg of Vitamin B12 
sublingually.3,4    
Key words needed to research these articles included Recurrent Aphthous Ulcers, RAU, 
Multivitamin, Omega-3 and Vitamin B12.  All three articles were researched using PubMed by 
the author. These articles were all published in English and published in peer-reviewed journals.  
These articles were chosen based on the relevance to the clinical question as well as being patient 
oriented outcomes. The inclusion criteria for this search included double-blind randomized 
control trials in which the outcome would directly affect the population involved.  The exclusion 
criteria included patients who did not suffer from recurrent aphthous ulcers, Patients with a 
history of smoking, a diagnosis of any systemic condition causing oral ulcerations or liver, heart, 
renal, immune deficiency diseases, anemia, use of NSAIDs on a regular basis, or currently 
pregnant or lactating.2,3,4  Statistics used in these studies include: Number needed to treat (NNT), 
P-Value, relative risk reduction (RRR) and absolute risk reduction (ARR).  Table 1 displays the 
demographics as well as characteristics observed in the study.   
!!!
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Table 1. Demographics and Characteristics of included studies 
Study Ty
pe
# 
Pts
Age (yrs) Inclusion  
Criteria
Exclusion  
Criteria
W/
D
Interventions
Lalla
(2012)
Doubl
e 
blind 
RCT
160 >18  
years 
old
>18 years 
with 
a valid 
history 
 of  > 3  
episodes 
of 
 aphthous 
 ulcers 
within  
12 months
Smoking, 
pregnancy, 
regular vitamin 
use, any over-the 
counter or Rx 
gents for RAS 
and a diagnosis of 
systemic 
condition causing 
oral ulcerations
60 1 Generic 
multivitamin by 
mouth 
containing U.S. 
reference daily 
intake of 
essential 
vitamins 
A,B1,B2,B3, 
B5,B6, B9,  
B12,C,D and E
Khouli
(2014)
Doubl
e 
blind 
RCT
50 >13  
years 
old
>13 years  
old, 
at least 
having 
minor 
RAU for  
> 1 year 
with > 1 
outbreak 
per month
Patients with 
liver, heart kidney 
disease, 
pregnancy or 
lactation, 
systemic diseases 
giving rise to oral 
ulcers, anemia, or 
use of steroids, or 
NSAIDs on a 
regular basis
0 1 g Omega-3 3 
times a day
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OUTCOMES MEASURED 
The outcomes measured in this study were the duration of current ulcerations, and 
reduction in outbreaks of new ulcerations as well as pain level but this is not a primary outcome 
in any of the studies2,3,4.  In Lalla’s study the unpaired t test and the Chi Squared test was used.2  
In the Khouli study the Oral Health Impact Profile-14 questionnaire was used along with the 
Kolmogorov-Smirnov test of normality were used as well as an unpaired t test and paired t test3.  
In the Volkov study the Chi-Squared test, the Mann-Whitney and Friedman test were used to 
determine patient outcomes.4  Patients were asked to subjectively report the number of 
outbreaks, duration in which the ulcers lasted and their pain levels in a diary in each study.2,3,4     
RESULTS 
This review investigated three RCTs including patients who suffered from Recurrent 
Aphthous Ulcers without an underlying systemic disease and compared the use of a daily 
multivitamin, Omega-3 or Vitamin B12 supplement for treatment of RAU. All three studies 
presented as dichotomous data and therefore assessment of efficacy of all three vitamin 
supplements was attainable2,3,4.   
Volkov 
4 
(2008)
Doubl
e 
blind 
RCT
58 >18  
years 
old
Patients 
suffering from 
RAS for > 1 
year with > 2 
outbreaks per 
month
Known systemic 
disease with 
associated oral 
ulcerations, B12 
treatments in the 
past, pregnant, 
immune deficient, 
nursing mothers 
or psychotic 
patients
0 Sublingual dose 
of 1000 mcg of 
Vitamin B12 for 
6 months
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In the Lalla Study those who smoked, used over-the-counter medications for RAU on a 
regular basis, were diagnosed with systemic diseases which caused oral ulcerations, or were 
currently pregnant or lactating were excluded from the study.2  The control group had 58 
participants receiving one generic multivitamin meeting RDI quality while the experimental 
group had 56 participants receiving the placebo treatment.  The study showed that compared to 
baseline the multivitamin had no noticeable benefit over the placebo group.  The number of new 
ulcers in the treatment arm was 4.19+4.74 with a p-value of 0.69 and in the control group was 
4.60+4.58 with a p-value of 0.40 showing no significance in the use of a multivitamin for the 
treatment of aphthous ulcers. The number needed to treat in this study was calculated to be 
-0.26.2 This means that for every 26 people taking a multivitamin supplement, 1 will not have a 
new occurrence of aphthous ulcers, compared to control. 
Table 2. Duration of RAS for Lalla Study.2 
Table 3. Incidence of New Episodes. 2 
In the Khouli study patients younger than thirteen years of age, patients with livers, heart, 
or kidney disease, systemic diseases with associated oral ulcers, anemia, the use of steroids on a 
Study Groups Duration in Days 
Mean+SD
p-value
Multivitamin 8.66+4.60 0.60
Placebo 8.99+5.22 0.60
Group Number of New 
Episodes (Total)
Number of New 
Episodes 
Mean+SD
p-value
Multivitamin 335 4.19+4.74 0.69
Placebo 329 4.60+4.58 0.40
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regular basis or pregnant and lactating females.  These patients were assessed on the number of 
new ulcers, average duration and their overall quality of life recorded on the Oral Health Impact 
Scale.3  The data collected showed a noticeable difference in the number of new ulcers from 
baseline compared to the placebo.  With the Omega-3 supplement 6.40+4.83 new ulcers went to 
0.76+1.05 and in the control group 6.72+4.60 changed to 6.28+4.99.3  The p-value was < 0.05 
showing a significance in the use of Omega-3 supplement for the treatment of aphthous ulcers.  
The numbers needed to treat was  
Table 4. Mean duration of ulcers in Khouli Study.3 
Table 5.  Mean number of monthly ulcers in Khouli Study.3 
In the Volkov study patients with known systemic diseases associated with oral 
ulcerations, vitamin B12treatments in the past, immunocompromised, pregnant, lactating or 
psychotic patients were excluded from this study.4 The Volkov study showed a significant 
decrease in the number of new outbreaks as well as the duration in which the ulcers remained.  
The number of new ulcers in the treatment arm showed 3.88+7.98 and in the control group 
13.39+23.56 exhibiting a significant difference with the use of Vitamin B12 supplement in the 
treatment of aphthous ulcers. The number needed to treat was calculated to be 0.02.  This means 
Timeline Omega-3 Group Placebo
Baseline 9.12+7.16 10.40+7.57
6 Months 1.76+1.89 8.60+4.26
Timeline Omega-3 Group Placebo
Baseline 6.40+4.83 6.72+4.60
6 Months 0.76+1.05 6.28+4.99
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for every 2 people taking the vitamin B12 supplements, 1 person will not have a recurrence of 
ulcers after treatment.   
!!
Table 6. Duration of Aphthous Ulcers in Volkov Study.4 
Table 7. Number of New Ulcers in Volkov Study.4 
Table 8. Treatment Effects 
DISSCUSSION 
Recurrent Aphthous Ulcers is a disorder in which ulcerations inhabit the oral cavity 
causing pain, decreased ability to eat and sometimes speak and ultimately affects the quality of 
life.1 There is no known cause of aphthous ulcers but there is an understanding of triggers for the 
outbreak of ulcers including: stress, allergies, genetics and diet.  Limitations of the study 
Groups Duration at 6 months 
Mean+SD
p-value
Intervention 1.98+3.77 0.05
Control 4.84+5.71 0.05
Group Number of New Ulcers 
Mean + SD
p-value
Intervention 3.88+7.98 P <0.05
Control 13.39+23.56 P<0.05
STUDY P-Value CER EER RRR ARR NNT
Lalla P < 0.69 51.9% 48.1% -0.07%. -3.8% -26
Khouli P < 0.05 - - - - -
Volkov P < 0.0001 32% 74% 1.31% -42% -2
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included compliance of subjects to takes medication as directed and report honestly as requested 
in the journals given.   
!
CONCLUSION 
This review and the chosen studies showed different outcomes for the treatment of 
Aphthous ulcers.  Two of the studies promised benefits from the use of Vitamin B12 and 
Omega-3 supplements for the treatment and prevention of recurring aphthous ulcers.  A 
Multivitamin containing RDI of vitamins A, B1, B2, B3, B5, B6, B9, B12, C, D, and E did not 
show promising results for treatment of RAS.  All studies resulted in no harmful effects for the 
subjects involved but only two studies showed evidence of improved quality of life.  Further 
studies with indications to utilize vitamin supplements for the treatment of RAS would benefit 
from a larger sample size.  In the future, developing a longitudinal study with a more robust 
sample size would be beneficial.  A sample size taken from various countries as opposed to just 
one institution would also improve study conditions.  Indicating when the ulcers are present to 
determine if subjects have certain triggers may be beneficial to narrowing inclusion and 
exclusion criteria.  Utilizing physicians of various fields such as ear nose and throat, oral 
surgeons and dentists to interpret patterns in the studies would be beneficial for study outcomes 
as well as patient follow ups.   
!
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